Efficacy of fecal microbiota transplantation in patients with Parkinson’s disease: clinical trial results from a randomized, placebo-controlled design

References

• Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257–21. doi:10.1016/S1474-4422(16)30230-7. PMID: 27751556.
   PubMed Web of Science ®Google Scholar
• Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583–1590. doi:10.1002/mds.25945. PMID: 24976103.
   PubMed Web of Science ®Google Scholar
• Bloem BR, Okun MS, Klein C. Parkinson’s disease. The Lancet. 2021;397(10291):2284–2303. doi:10.1016/S0140-6736(21)00218-X. PMID: 33848468.
   PubMed Web of Science ®Google Scholar
• Liddle RA. Parkinson’s disease from the gut. Brain Res. 2018;1693:201–206. doi:10.1016/j.brainres.2018.01.010. PMID: 29360467.
   PubMed Web of Science ®Google Scholar
• Pereira PAB, Aho VTE, Paulin L, Pekkonen E, Auvinen P, Scheperjans F. Oral and nasal microbiota in Parkinson’s disease. Parkinsonism Relat Disord. 2017;38:61–67. doi:10.1016/j.parkreldis.2017.02.026. PMID: 28259623.
   PubMed Web of Science ®Google Scholar
• Kuan WL, Stott K, He X, Wood TC, Yang S, Kwok JCF, Hall K, Zhao Y, Tietz O, Aigbirhio FI, et al. Systemic α-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson’s disease. Mol Psychiatry. 2021;26(2):556–567. doi:10.1038/s41380-019-0608-9. PMID: 31758091.
   PubMed Web of Science ®Google Scholar
• Yemula N, Dietrich C, Dostal V, Hornberger M. Parkinson’s disease and the gut: symptoms, nutrition, and microbiota. J Parkinsons Dis. 2021;11(4):1491–1505. doi:10.3233/JPD-212707. PMID: 34250955.
   PubMedGoogle Scholar
• Wang Q, Luo Y, Ray Chaudhuri K, Reynolds R, Tan EK, Pettersson S. The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options. Brain. 2021;144(9):2571–2593. doi:10.1093/brain/awab156. PMID: 33856024.
   PubMedGoogle Scholar
• Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323(6):548–560. doi:10.1001/jama.2019.22360. PMID: 32044947.
   PubMed Web of Science ®Google Scholar
• Miller KM, Mercado NM, Sortwell CE. Synucleinopathy-associated pathogenesis in Parkinson’s disease and the potential for brain-derived neurotrophic factor. NPJ Parkinsons Dis. 2021;7(1):35. doi:10.1038/s41531-021-00179-6. PMID: 33846345.
   PubMed Web of Science ®Google Scholar
• Kalia LV, Lang AE. Parkinson’s disease. The Lancet. 2015;386(9996):896–912. doi:10.1016/S0140-6736(14)61393-3. PMID: 25904081.
   PubMed Web of Science ®Google Scholar
• Klingelhoefer L, Reichmann H. Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors. Nat Rev Neurol. 2015;11(11):625–636. doi:10.1038/nrneurol.2015.197. PMID: 26503923.
   PubMed Web of Science ®Google Scholar
• Hirayama M, Ohno K. Parkinson’s disease and gut microbiota. Ann Nutr Metab. 2021;77(Suppl 2):28–35. doi:10.1159/000518147. PMID: 34500451.
   PubMedGoogle Scholar
• Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R, Soleimanpour S. A comprehensive review on the role of the gut microbiome in Human neurological disorders. Clin Microbiol Rev. 2022;35(1):e0033820. doi:10.1128/CMR.00338-20. PMID: 34985325.
   PubMed Web of Science ®Google Scholar
• Shen T, Yue Y, He T, Huang C, Qu B, Lv W, Lai HY. The association between the gut microbiota and Parkinson’s disease, a meta-analysis. Front Aging Neurosci. 2021;13:636545. doi:10.3389/fnagi.2021.636545. PMID: 33643026.
   PubMed Web of Science ®Google Scholar
• Heinzel S, Aho VTE, Suenkel U, von Thaler AK, Schulte C, Deuschle C, Paulin L, Hantunen S, Brockmann K, Eschweiler GW, et al. Gut microbiome signatures of risk and prodromal markers of Parkinson disease. Ann Neurol. 2021;90(3):E1–E12. doi:10.1002/ana.26128. PMID: 34021620.
   PubMed Web of Science ®Google Scholar
• Heinzel S, Aho VTE, Suenkel U, von Thaler AK, Schulte C, Deuschle C, Paulin L, Hantunen S, Brockmann K, Eschweiler GW, et al. Retracted: gut microbiome signatures of risk and prodromal markers of Parkinson disease. Ann Neurol. 2020;88(2):320–331. doi:10.1002/ana.25788. PMID: 32441370.
   PubMed Web of Science ®Google Scholar
• Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, et al. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease. Cell. 2016;167(6):1469–1480.e12. doi:10.1016/j.cell.2016.11.018. PMID: 27912057.
   PubMed Web of Science ®Google Scholar
• Gazerani P. Probiotics for Parkinson’s disease. Int J Mol Sci. 2019;20(17):4121. doi:10.3390/ijms20174121. PMID: 31450864.
   PubMed Web of Science ®Google Scholar
• Sun MF, Zhu YL, Zhou ZL, Jia XB, Xu YD, Yang Q, Cui C, Shen YQ. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: gut microbiota, glial reaction and TLR4/TNF-alpha signaling pathway. Brain Behav Immun. 2018;70:48–60. doi:10.1016/j.bbi.2018.02.005. PMID: 29471030.
   PubMed Web of Science ®Google Scholar
• Kuai XY, Yao XH, Xu LJ, Zhou YQ, Zhang LP, Liu Y, Pei SF, Zhou CL. Evaluation of fecal microbiota transplantation in Parkinson’s disease patients with constipation. Microb Cell Fact. 2021;20(1):98. doi:10.1186/s12934-021-01589-0. PMID: 33985520.
   PubMed Web of Science ®Google Scholar
• Xue LJ, Yang XZ, Tong Q, Shen P, Ma SJ, Wu SN, Zheng JL, Wang HG. Fecal microbiota transplantation therapy for Parkinson’s disease: a preliminary study. Med. 2020;99(35):e22035. doi:10.1097/MD.0000000000022035. PMID: 32871960.
   PubMed Web of Science ®Google Scholar
• Segal A, Zlotnik Y, Moyal-Atias K, Abuhasira R, Ifergane G. Fecal microbiota transplant as a potential treatment for Parkinson’s disease - a case series. Clin Neurol Neurosurg. 2021;207:106791. doi:10.1016/j.clineuro.2021.106791. PMID: 34237681.
   PubMed Web of Science ®Google Scholar
• Horvath K, Aschermann Z, Kovacs M, Makkos A, Harmat M, Janszky J, Komoly S, Karadi K, Kovacs N. Minimal clinically important differences for the experiences of daily living parts of movement disorder society–sponsored unified Parkinson’s disease rating scale. Mov Disord. 2017;32(5):789–793. doi:10.1002/mds.26960. PMID: 28218413.
   PubMed Web of Science ®Google Scholar
• Socala K, Doboszewska U, Szopa A, Serefko A, Wlodarczyk M, Zielinska A, Poleszak E, Fichna J, Wlaz P. The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol Res. 2021;172:105840. doi:10.1016/j.phrs.2021.105840. PMID: 34450312.
   PubMed Web of Science ®Google Scholar
• Li N, Chen H, Cheng Y, Xu F, Ruan G, Ying S, Tang W, Chen L, Chen M, Lv L, et al. Fecal microbiota transplantation relieves gastrointestinal and autism symptoms by improving the gut microbiota in an open-label study. Front Cell Infect Microbiol. 2021;11:759435. doi:10.3389/fcimb.2021.759435. PMID: 34737978.
   PubMed Web of Science ®Google Scholar
• DuPont HL, Suescun J, Jiang ZD, Brown EL, Essigmann HT, Alexander AS, DuPont AW, Iqbal T, Utay NS, Newmark M, et al. Fecal microbiota transplantation in Parkinson’s disease-A randomized repeat-dose, placebo-controlled clinical pilot study. Front Neurol. 2023;14:1104759. doi:10.3389/fneur.2023.1104759. PMID: 36937520.
   PubMedGoogle Scholar
• Tian H, Ge X, Nie Y, Yang L, Ding C, McFarland LV, Zhang X, Chen Q, Gong J, Li N, et al. Fecal microbiota transplantation in patients with slow-transit constipation: a randomized, clinical trial. PLoS ONE. 2017;12(2):e0171308. doi:10.1371/journal.pone.0171308. PMID: 28158276.
   PubMed Web of Science ®Google Scholar
• Aroniadis OC, Brandt LJ, Oneto C, Feuerstadt P, Sherman A, Wolkoff AW, Kassam Z, Sadovsky RG, Elliott RJ, Budree S, et al. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2019;4(9):675–685. doi:10.1016/s2468-1253(19)30198-0. PMID: 31326345.
   PubMed Web of Science ®Google Scholar
• Marx W, Lane M, Hockey M, Aslam H, Berk M, Walder K, Borsini A, Firth J, Pariante CM, Berding K, et al. Diet and depression: exploring the biological mechanisms of action. Mol Psychiatry. 2021;26(1):134–150. doi:10.1038/s41380-020-00925-x. PMID: 33144709.
   PubMed Web of Science ®Google Scholar
• Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, Burmann J, Fassbender K, Schwiertz A, Schafer KH. Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls. Parkinsonism Relat Disord. 2016;32:66–72. doi:10.1016/j.parkreldis.2016.08.019. PMID: 27591074.
   PubMed Web of Science ®Google Scholar
• Ma B, Liang J, Dai M, Wang J, Luo J, Zhang Z, Jing J. Altered gut microbiota in Chinese children with autism spectrum disorders. Front Cell Infect Microbiol. 2019;9:40. doi:10.3389/fcimb.2019.00040. PMID: 30895172.
   PubMed Web of Science ®Google Scholar
• Liu P, Wu L, Peng G, Han Y, Tang R, Ge J, Zhang L, Jia L, Yue S, Zhou K, et al. Altered microbiomes distinguish Alzheimer’s disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain Behav Immun. 2019;80:633–643. doi:10.1016/j.bbi.2019.05.008. PMID: 31063846.
   PubMed Web of Science ®Google Scholar
• Tan AH, Chong CW, Song SL, Teh CSJ, Yap IKS, Loke MF, Tan YQ, Yong HS, Mahadeva S, Lang AE, et al. Altered gut microbiome and metabolome in patients with multiple system atrophy. Mov Disord. 2018;33(1):174–176. doi:10.1002/mds.27203. PMID: 29083071.
   PubMed Web of Science ®Google Scholar
• Mazzini L, Mogna L, De Marchi F, Amoruso A, Pane M, Aloisio I, Cionci NB, Gaggia F, Lucenti A, Bersano E, et al. Potential role of gut microbiota in ALS pathogenesis and possible novel therapeutic strategies. J Clin Gastroenterol. 2018;52(Suppl 1):S68–S70. Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017. doi:10.1097/MCG.0000000000001042. PMID: 29782468.
   PubMedGoogle Scholar
• Sun MF, Shen YQ. Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s disease. Ageing Res Rev. 2018;45:53–61. doi:10.1016/j.arr.2018.04.004. PMID: 29705121.
   PubMed Web of Science ®Google Scholar
• Roy Sarkar S, Banerjee S. Gut microbiota in neurodegenerative disorders. J Neuroimmunol. 2019;328:98–104. doi:10.1016/j.jneuroim.2019.01.004. PMID: 30658292.
   PubMed Web of Science ®Google Scholar
• Meyer K, Lulla A, Debroy K, Shikany JM, Yaffe K, Meirelles O, Launer LJ. Association of the gut microbiota with cognitive function in midlife. JAMA Netw Open. 2022;5(2):e2143941. doi:10.1001/jamanetworkopen.2021.43941. PMID: 35133436.
   PubMed Web of Science ®Google Scholar
• Kaiyrlykyzy A, Kozhakhmetov S, Babenko D, Zholdasbekova G, Alzhanova D, Olzhayev F, Baibulatova A, Kushugulova AR, Askarova S. Study of gut microbiota alterations in Alzheimer’s dementia patients from Kazakhstan. Sci Rep. 2022;12(1):15115. doi:10.1038/s41598-022-19393-0. PMID: 36068280.
   PubMed Web of Science ®Google Scholar
• Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, Shannon KM. Colonic bacterial composition in Parkinson’s disease. Mov Disord. 2015;30(10):1351–1360. doi:10.1002/mds.26307. PMID: 26179554.
   PubMed Web of Science ®Google Scholar
• Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A. Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis. 2021;7(1):27. doi:10.1038/s41531-021-00156-z. PMID: 33692356.
   PubMed Web of Science ®Google Scholar
• Holvoet T, Joossens M, Vazquez-Castellanos JF, Christiaens E, Heyerick L, Boelens J, Verhasselt B, van Vlierberghe H, De Vos M, Raes J, et al. Fecal microbiota transplantation reduces symptoms in some patients with irritable bowel syndrome with predominant abdominal bloating: short- and long-term results from a placebo-controlled randomized trial. Gastroenterology. 2021;160(1):145–157.e8. doi:10.1053/j.gastro.2020.07.013. PMID: 32681922.
   PubMed Web of Science ®Google Scholar
• Vendrik KEW, Ooijevaar RE, de Jong PRC, Laman JD, van Oosten BW, van Hilten JJ, Ducarmon QR, Keller JJ, Kuijper EJ, Contarino MF. Fecal Microbiota Transplantation in Neurological Disorders. Front Cell Infect Microbiol. 2020;10:98. doi:10.3389/fcimb.2020.00098. PMID: 32266160.
   PubMed Web of Science ®Google Scholar
• Di Modica M, Gargari G, Regondi V, Bonizzi A, Arioli S, Belmonte B, De Cecco L, Fasano E, Bianchi F, Bertolotti A, et al. Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer. Cancer Res. 2021;81(8):2195–2206. doi:10.1158/0008-5472.CAN-20-1659. PMID: 33483370.
   PubMed Web of Science ®Google Scholar
• Xu F, Li N, Wang C, Xing H, Chen D, Wei Y. Clinical efficacy of fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: a randomized, placebo-controlled clinic study. BMC Gastroenterol. 2021;21(1):54. doi:10.1186/s12876-021-01630-x. PMID: 33549047.
   PubMed Web of Science ®Google Scholar
• Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, Alexander H, Alm EJ, Arumugam M, Asnicar F, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852–857. doi:10.1038/s41587-019-0209-9. PMID: 31341288.
   PubMed Web of Science ®Google Scholar
• Price MN, Dehal PS, Arkin AP, Poon AFY. FastTree 2–approximately maximum-likelihood trees for large alignments. PLoS ONE. 2010;5(3):e9490. doi:10.1371/journal.pone.0009490. PMID: 20224823.
   PubMed Web of Science ®Google Scholar
• Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR, Taylor CM, Huttenhower C, Langille MGI. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020;38(6):685–688. doi:10.1038/s41587-020-0548-6. PMID: 32483366.
   PubMed Web of Science ®Google Scholar
• Langmead B, Salzberg SL. Fast gapped-read alignment with bowtie 2. Nat Methods. 2012;9(4):357–359. doi:10.1038/nmeth.1923. PMID: 22388286.
   PubMed Web of Science ®Google Scholar
• Nousias O, Montesanto F. Metagenomic profiling of host-associated bacteria from 8 datasets of the red alga porphyra purpurea with MetaPhlAn3. Mar Genomics. 2021;59:100866. doi:10.1016/j.margen.2021.100866. PMID: 33812777.
   PubMed Web of Science ®Google Scholar
• Beghini F, McIver LJ, Blanco-Miguez A, Dubois L, Asnicar F, Maharjan S, Mailyan A, Manghi P, Scholz M, Thomas AM, et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife. 2021;10. PMID: 33944776. doi:10.7554/eLife.65088.
   PubMed Web of Science ®Google Scholar
• Dan Z, Mao X, Liu Q, Guo M, Zhuang Y, Liu Z, Chen K, Chen J, Xu R, Tang J, et al. Altered gut microbial profile is associated with abnormal metabolism activity of autism spectrum disorder. Gut Microbes. 2020;11(5):1246–1267. doi:10.1080/19490976.2020.1747329. PMID: 32312186.
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335–336. doi:10.1038/nmeth.f.303. PMID: 20383131.
   PubMed Web of Science ®Google Scholar